Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey

Annals of Surgical Oncology

Volumn 21, Issue 13, 2014, Pages 4104-4108

  Beitsch, Peter D ^a   Whitworth, Pat W ^b  

^a Dallas Breast Center and Dallas Surgical Group   (United States)

^b Nashville Breast Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGEON; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MEDICAL EDUCATION; QUESTIONNAIRE; SELF EVALUATION; SKILL; SURGEON; WORK EXPERIENCE; BLOOD; BREAST TUMOR; CLINICAL PRACTICE; FEMALE; GENERAL SURGERY; GENETIC PREDISPOSITION; GENETICS; GOVERNMENT REGULATION; HEALTH SURVEY; MEDICAL SOCIETY; MUTATION; ONCOLOGY; PATIENT SELECTION; PEDIGREE; PHYSICIAN ATTITUDE; PREDICTIVE VALUE; RISK ASSESSMENT; UNITED STATES;

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; TUMOR MARKER;

BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; GENERAL SURGERY; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GOVERNMENT REGULATION; HEALTH SURVEYS; HUMANS; MEDICAL ONCOLOGY; MUTATION; PATIENT SELECTION; PEDIGREE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; SOCIETIES, MEDICAL; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84911958519     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3711-9     Document Type: Article

References (17)

1. Cho MK, Sankar P, Wolpe PR, Godmilow L. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test. Am J Med Genet. 1999;83:157–63.
2. American College of Surgeons Cancer Programs. National Accreditation Program for Breast Centers: background statement. Available at: http://napbc-breast.org/. Accessed January 28, 2014.
3. Genetic Evaluation and Management. Standard 2.16. Cancer risk assessment, genetic counseling and genetic testing services are provided or referred. In: 2013 breast center standards manual. National Accreditation Program for Breast Centers. Chicago, IL: American College of Surgeons; 2013. Available at: http://napbc-breast.org/standards/2013standardsmanual.pdf#52. Accessed January 29, 2014.
4. Cigna medical coverage policy. Effective September 15, 2013. Genetic testing for susceptibility to breast and ovarian cancer (e.g., BRCA1 and BRCA2). Available at: http://www.elsevierbi.com/~/media/Supporting%20Documents/The%20Gray%20Sheet/39/37/mm_0001_coveragepositioncriteria_genetic_testing_for_breast_and_ovarian_cancer.pdf/. Accessed January 29, 2014.
5. American Society of Clinical Oncology. Policy statement: new Cigna policy on cancer genetic testing poses risks to high quality cancer care. September 6, 2013. Available at: http://www.asco.org/advocacy/new-cigna-policy-cancer-genetic-testing-poses-risks-high-quality-cancer-care/. Accessed January 29, 2014.
6. Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19:1732–7.
7. Beitsch PD, Lerner AG, Laidley AL, Tafra L, Edwards MJ. Who are we and what do we think? Am J Surg. 2003;186:321–3.
8. Schubart JR, Dominici LS, Farnan M, et al. Shared decision making in breast cancer: national practice patterns of surgeons. Ann Surg Oncol. 2013;20:3323–9.
9. Chipman J, Drohan B, Blackford A, Parmigiani G, Hughes K, Bosinoff P. Providing access to risk prediction tools via the HL7 XML-formatted risk Web service. Breast Cancer Res Treat. 2013;140:187–93.
10. Lu KH, Wood ME, Daniels M, et al. American Society of Clinical Oncology expert statement: collection and use of a cancer family history for oncology providers. J Clin Oncol., 2014; 32(8):833–40.
11. Biswas S, Atienza P, Chipman J, et al. Simplifying clinical use of the genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2013;139:571–9.
12. UT Southwestern Medical Center at Dallas and The BayesMendel Group. CancerGene: BRCA 1 and BRCA 2 mutation probabilities. Available at: http://www4.utsouthwestern.edu/breasthealth/cagene/. Accessed February 22, 2014.
13. Starting a high-risk program with risk models. Premeeting course, 15th annual meeting of the American Society of Breast Surgeons, Las Vegas, NV, April 30–May 4, 2014. Available at: https://www.breastsurgeons.org/new_layout/annual_meeting2014/premeeting_courses.php/. Accessed February 22, 2014.
14. Risk assessment course. 24th Interdisciplinary Breast Center Conference, National Consortium of Breast Centers. Las Vegas, NV, March 15–19, 2014. Available at: http://www2.breastcare.org/ncbc-conference-tickets/. Accessed February 22, 2014.
15. Surgeon assessment for hereditary cause of breast cancer quality measure. American Society of Breast Surgeons, March 7, 2011. Available at: https://www.breastsurgeons.org/new_layout/about/statements/QM/ASBrS_Hereditary_cause_of_breast_cancer.pdf/. Accessed February 22, 2014.
16. Schwartz MD, Valdimarsdottir HB, Peshkin BN, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014, 32(7):618–26.
17. Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? J Clin Oncol. 2014; 32(7):611–2.